Diabetology Xagena

Xagena Mappa
Medical Meeting

Search results for "Dulaglutide"

Positive top-line results of two additional phase III AWARD trials for Dulaglutide, an investigational, long-acting glucagon-like peptide 1 ( GLP-1 ) receptor agonist being studied as a once-weekly tr ...

Dulaglutide ( Trulicity ) significantly improves A1C ( average blood sugar concentration over two to three months ) when added to ongoing treatment with a sodium-glucose co-transporter-2 ( SGLT-2 ) in ...